EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR) EAE

Friday, 18. October 2019 17:00
--------------------------------------------------------------------------------
  Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by
  euro adhoc with the aim of a Europe-wide distribution. The issuer is
  responsible for the content of this announcement.
--------------------------------------------------------------------------------

personal data:

responsible party:

name: aws Mittelstandsfonds Beteiligungs GmbH & Co KG (legal person)

--------------------------------------------------------------------------------

reason:

reason: responsible party is a legal person associate to a person with
managerial responsibilities
name and surname: Mag.(FH) Karl Lankmayr
function: Member of an administrative or supervisory board

--------------------------------------------------------------------------------

issuer information:

name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405

--------------------------------------------------------------------------------

information about deal:

ISIN: ATMARINOMED6
description of the financial instrument: share
type: disposition
date: 16.10.2019; UTC+02:00
market: Outside the trading venue
currency: Euro

price               volume
           EUR 95.00               57,500

total volume: 57,500
total price: EUR 5,462,500
average price: EUR 95,00

--------------------------------------------------------------------------------

Further inquiry note:

Dr. Eva Prieschl-Grassauer
Chief Scientific Officer, Marinomed
Veterinärplatz 1, 1210 Vienna, Austria
T +43 (0)1 250 77 4460
E-Mail: eva.prieschl@marinomed.com
http://www.marinomed.com

Roland Mayrl
Managing Partner, Metrum Communications
Bauernmarkt 10/19, 1010 Vienna, Austria
T +43 (0) 1 504 69 87 331
E-Mail: r.mayrl@metrum.at
http://www.metrum.at

end of announcement                         euro adhoc
--------------------------------------------------------------------------------

issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:         office@marinomed.com
WWW:          www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English

EAX0009    2019-10-18/17:00

Related Links: Marinomed Biotech AG
Author:
Ad-hoc-Mitteilung übermittelt durch euro adhoc.
Für den Inhalt ist der Emittent verantwortlich.